Prunus

Prunus: A Comprehensive Encyclopedic Reference

1. Identity and Botanical Classification

Prunus L. is a diverse genus of deciduous and evergreen trees and shrubs belonging to the family Rosaceae (subfamily Amygdaloideae), comprising approximately 400–430 species widely distributed across temperate regions. The genus is traditionally placed within the rose family Rosaceae as part of the subfamily Prunoideae (or Amygdaloideae), where it is the largest genus. It is sometimes placed in its own family, Prunaceae (or Amygdalaceae).

The genus consists of about 430 species distributed among five sub-genera — namely, Padus, Amygdalus, Cerasus, Prunophora, and Laurocerasus — growing chiefly in the temperate regions of the Northern Hemisphere. They are known to be distributed worldwide, including Asian countries, Russia, Europe, North America, and African countries.

Prunus is a genus of trees and shrubs that includes (among many others) the fruits plums, cherries, peaches, nectarines, apricots, and almonds. The fruit is a fleshy drupe (a "prune") with a single relatively large, hard-coated seed (a "stone"). The fleshy mesocarp surrounding the endocarp is edible, while the endocarp itself forms a hard, inedible shell enclosing the seed (or "kernel"), which is edible in many species (such as almonds) but toxic in others (such as certain apricots).

Several species are cultivated globally for ornamental purposes and for commercially important fruits such as plums, almonds, peaches, nectarines, cherries, and apricots. Among the most medicinally and nutritionally significant species are:

• Prunus africana (Hook. f.) Kalkm. — African cherry / African plum / Pygeum
• Prunus cerasus L. — Sour (tart) cherry / Montmorency cherry / Morello cherry
• Prunus dulcis (Mill.) D.A. Webb (syn. Prunus amygdalus Batsch, Amygdalus communis L.) — Almond
• Prunus armeniaca L. — Apricot
• Prunus mume (Siebold) Siebold & Zucc. — Japanese apricot / Chinese plum (Ume)
• Prunus spinosa L. — Blackthorn / Sloe
• Prunus persica (L.) Batsch — Peach
• Prunus domestica L. — European plum / Prune
• Prunus avium L. — Sweet cherry

Common Forms and Preparations

Besides being eaten fresh, most Prunus fruits are also commonly used to make processed foods and beverages such as canned and dried fruit, fruit juices (e.g., cherry and prune juice), jam, gelatine desserts, and roasted seeds. Dietary supplement preparations vary by species:

• P. africana (Pygeum): Dietary supplements that contain pygeum are made from the bark of the tree.
• P. cerasus (Tart cherry): Marketed as juice concentrate, freeze-dried powder capsules, and standardised extracts.
• P. dulcis (Almond): Consumed as whole kernels, almond flour, almond oil, and almond skin/hull extracts used in research settings.
• P. mume (Ume) is one of the most ancient medicinal herbs and health foods commonly used in Asian countries, widely used as a constituent of many medicinal preparations and as a food ingredient.

2. Traditional and Historical Use

2.1 African Traditional Medicine — Prunus africana

Commonly known as African cherry, African plum, African prune, or bitter almond, P. africana belongs to the Rosaceae family, subfamily Amygdaloideae (syn. Prunoideae), and subgenus Laurocerasus. The term "Prunus" denotes the plum-like shape of its fruit, and "africana" signifies its endemic existence in the Afromontane forests, where locals utilise it for various medicinal and household purposes.

Prunus africana has been used for generations in African traditional medicine to treat prostate cancer. It is also utilised in traditional medicine to manage many ailments such as malaria, fevers, mental illness, and gastrointestinal disorders. An African prune (plum) tree found in tropical Africa, bark extract from Pygeum africanum has been used in Europe as a prevention and treatment of prostate disorders including benign prostatic hypertrophy (BPH).

For the last 35 years, the African cherry (Prunus africana (Hook. f.) Kalm.) has been used in the treatment of benign prostatic hyperplasia and other disorders. The bark, from which the treatment is derived, is entirely wild-collected. The major exporters of bark include Cameroon, Madagascar, Equatorial Guinea, and Kenya. Groupe Fournier of France and Indena of Italy produce 86% of the world's bark extract, both for their own products and for the free market.

2.2 East Asian Traditional Medicine — Prunus mume

Prunus mume (Siebold) Siebold & Zucc. is an Asian plum species belonging to the Rosaceae family, known as wu mei (Chinese: 乌梅) in China, Japanese apricot or ume in Japan, and maesil or oumae in Korea. The plant is commonly cultivated throughout most of China and is native to Japan and Korea. The fruit has been used as a medicinal herb and health food in East Asian countries for more than 2,000 years. In China, the dried fruit is listed in the earliest pharmacopoeia of traditional Chinese medicine (TCM), Shen Nong Ben Cao Jing, compiled during the Han Dynasty, in approximately AD 220. In Japan, the earliest record is found in a medical monograph called Ishinho, published in AD 984.

Extracts of the fruit of Prunus mume (Rosaceae) have been used for a long time in Eastern Asia, in many culinary and medicinal preparations. The plant originates from the south of mainland China (named méi) and was introduced later in Japan (ume), Korea (maesil), and Vietnam (mai or mo).

2.3 Traditional Use of Apricot — Prunus armeniaca

The apricot plant is thought to originate from the northern, north-western, and north-eastern provinces of China, although some data show that it may also come from Korea or Japan. The apricot fruit is used medicinally to treat a variety of ailments, including use as an antipyretic, antiseptic, anti-inflammatory, emetic, and ophthalmic remedy. The Chinese and Korean pharmacopeias describe the apricot seed as an herbal medicinal product. Various parts of the apricot plant are used worldwide for their anticancer properties, either as a primary remedy in traditional medicine or as a complementary or alternative medicine.

2.4 Traditional Use of Peach — Prunus mira and Prunus persica

Prunus mira is used in traditional Chinese medicine for the treatment of dysmenorrhoea, injury, intestinal dryness, constipation, and other diseases, and in Tibetan medicine for the treatment of hair, eyebrows, and beard shedding.

2.5 Traditional Use of Blackthorn — Prunus spinosa

The fresh fruits of Prunus spinosa L., a wild plum species, are traditionally used for dietary purposes and medicinal applications in disorders related to inflammation and oxidative stress. Its application in compound recipes, recommended among others in various cardiac complaints such as inflammation of the heart muscle, cardiac neurosis, or atherosclerosis, as well as the results of preliminary ex vivo and in vivo animal studies, prompted investigation of this plant material and its possible molecular effects in the context of cardiovascular disease.

2.6 Prunus Species in South Asian Medicine

The genus Prunus, comprising around 430 species, is a vast and important genus of family Rosaceae, subfamily Amygdaloideae. Among all 430 species, around 19 important species are commonly found in the Indian subcontinent due to their broad nutritional and economic importance. Some of the most common species include Prunus amygdalus, Prunus persica, Prunus armeniaca, Prunus avium, Prunus cerasus, Prunus cerasoides, Prunus domestica, and Prunus mahaleb.

Beyond their economic value, numerous Prunus species have a long history of use in traditional healthcare systems for their ethnomedicinal properties. Plant species belonging to the genus Prunus are widely used traditionally for the treatment of various disorders.

3. Key Constituents and Active Compounds

3.1 Polyphenols and Phenolic Compounds (Genus-Wide)

Prunus fruits are recognised to be rich sources of polyphenols with health-promoting effects. In P. spinosa fruits, fifty-seven phenolic components have been identified by UHPLC-PDA-ESI-MS³, including fractions enriched in phenolic acids (caffeoyl-, coumaroyl-, and feruloylquinic acids), flavonoids (mostly quercetin mono-, di-, and triglycosides), condensed proanthocyanidins, and anthocyanins (cyanidin and peonidin glycosides).

The almond skin, constituting only 4–8% of kernel weight, contains concentrated polyphenolic compounds including flavonoids (87–135 mg/100 g) and proanthocyanidins (61–162 mg/100 g), contributing substantially to antioxidant capacity.

3.2 Anthocyanins (Especially in Tart Cherry — P. cerasus)

Tart Montmorency cherries (MC) are a particularly rich source of anthocyanins and other polyphenols that have been shown to elicit antioxidant, anti-inflammatory, and vasomodulatory actions. The primary anthocyanins in tart cherries include cyanidin-3-glucosylrutinoside and cyanidin-3-rutinoside. Anti-inflammatory and sleep-promoting properties are attributed in part to anthocyanins, which may minimise tryptophan degradation while increasing bioavailability for serotonin synthesis. Additionally, sleep-promoting effects arise from large naturally occurring levels of melatonin.

3.3 Phytosterols and Triterpenes (P. africana)

The bark of Prunus africana may contain atranorin, atraric acid, beta-sitosterol and its esters, ferulic acid and its esters, and N-butylbenzene sulfonamide — compounds that have been shown to improve the conditions of benign prostatic hyperplasia.

Bioactive constituents derived from bark extracts, measured in mg/kg (w/w) in increasing order, include: lauric acid (18), myristic acid (22), n-docosanol (25), ferulic acid (49), β-sitostenone (198), β-sitosterol (490), and ursolic acid (743).

The pharmacological properties of P. africana are attributed to a spectrum of bioactive compounds, including tannins, saponins, alkaloids, flavonoids, terpenoids, phytosterols, and fatty acids.

3.4 Cyanogenic Glycosides — Amygdalin and Prunasin

Amygdalin is one of the most studied secondary metabolites of the Prunus genus. It is a cyanogenic glycoside which was initially obtained from bitter almond seeds and is a major component of the seeds of plants such as apricots, almonds, peaches, apples, and other rosaceous plants.

The distinction between sweet and bitter almond varieties is primarily attributed to the presence or absence of cyanogenic glycosides. Bitter almonds contain substantial amounts of amygdalin and prunasin, which upon enzymatic hydrolysis release hydrogen cyanide (HCN), rendering them potentially toxic. In contrast, sweet almond varieties utilised for consumption contain negligible or undetectable levels of these cyanogenic compounds.

Amygdalin and prunasin are common among plants of the family Rosaceae, particularly the genus Prunus. A total of 192 compounds have been isolated from different parts of P. mume, including phenolics, organic acids, steroids, terpenes, benzyl glycosides, cyanogenic glycosides, furfurals, lignans, alkaloids, amino acids, and other compounds.

3.5 Fatty Acids and Macronutrients (Almond — P. dulcis)

Approximately 50% of the almond weight is fat, mostly monounsaturated fatty acids (MUFA), which are associated with the reduction of low-density lipoprotein cholesterol (LDL-c). Therefore, almonds are associated with benefits for cardiovascular health and obesity-related diseases. These benefits are mainly ascribed to their nutrient composition being low in saturated fatty acids (SFA) and rich in unsaturated fatty acids (91–94% of fats are oleic acid and linoleic acid), as well as α-tocopherol, and containing fibre, phytosterols, and proteins.

3.6 Carbohydrate Profile

Apricot, cherry, sour cherry, and plum juices are dominated by sugars, which play a key role in defining the fruit's taste and flavour and make them good phytomarkers for species differentiation. The carbohydrates profile differs among analysed fruit juices; strong correlations exist between sucrose and apricot juice, while fructose and glucose are correlated with cherry and sour cherry juices.

4. Mechanisms of Action

4.1 Anti-inflammatory Pathways

Chemical analysis and pharmacological studies have confirmed that lipophilic extract of pygeum bark has two categories of active constituents: (1) phytosterols, including beta-sitosterol, which exert anti-inflammatory effects by interfering with the formation of hormone-like substances in the body (prostaglandins) that tend to accumulate in the prostate of men with benign prostatic hyperplasia (BPH).

Hydroalcoholic extracts and phenolic-enriched fractions of P. spinosa fruits reveal significant ability to modulate pro-oxidant, pro-inflammatory, and anti-inflammatory functions of human neutrophils and peripheral blood mononuclear cells (PBMCs): they strongly downregulate the release of reactive oxygen species, TNF-α, and neutrophil elastase, and upregulate the secretion of IL-10. Correlation studies and experiments on pure compounds indicated a significant contribution of polyphenols to these effects.

4.2 Antioxidant Mechanisms

Oxidative post-translational modifications of fibrinogen, a multifunctional blood plasma protein essential for haemostasis, are associated with the pathogenesis of cardiovascular disorders (CVDs). Prunus spinosa flower is a herbal medicine used in an adjuvant treatment of CVDs and is rich in polyphenolic antioxidants. Phytochemically standardised P. spinosa flower extracts and their primary native polyphenols and potential phenolic metabolites evaluated in vitro revealed that the tested analytes at in vivo relevant levels (1–5 µg/mL) considerably reduced the structural changes in the fibrinogen molecule under oxidative stress conditions induced by peroxynitrite.

4.3 Antiandrogenic and Antiangiogenic Mechanisms (P. africana)

Multiple studies have documented the anti-inflammatory, antimicrobial, antiandrogenic, antiangiogenic, antioxidant, antidipeptidyl peptidase-4 activity, analgesic, and astringent properties of P. africana extracts.

4.4 Uric Acid Reduction

Tart cherry (Prunus cerasus) juice has demonstrated inhibitory effects on xanthine oxidoreductase activity, with documented hypouricaemic and antioxidant effects in animal studies.

4.5 Lipid Metabolism Modulation

Modern pharmacological studies have validated multiple therapeutic activities for almonds: antihyperlipidaemic effects reducing total cholesterol and LDL-C; antidiabetic action through DPP-IV inhibition and enhanced insulin sensitivity; cardioprotective benefits via improved lipid profiles and reduced inflammation (decreased E-selectin and CRP); and potent antioxidant activity increasing SOD and glutathione peroxidase.

5. Scientific Evidence by Area of Use

5.1 Benign Prostatic Hyperplasia (BPH) — Prunus africana

The most robustly clinically studied application for any single Prunus species in the supplement context is the use of P. africana (Pygeum) bark extract for BPH.

Systematic Review / Cochrane Evidence: The key question examined was whether extracts of Pygeum africanum are (1) more effective than placebo in the treatment of BPH, (2) as effective as standard pharmacologic BPH treatments, and (3) have fewer side effects compared to standard BPH drugs. The 18 randomised controlled trials analysed involved 1,562 men and lasted from 30 to 122 days. Men using Pygeum africanum were more than twice as likely to report an improvement in overall symptoms as men receiving the non-active placebo. Their peak flow of urine increased by 23%.

Adverse effects of Pygeum africanum were mild and comparable to placebo. The most commonly reported side effect was gastrointestinal discomfort. The trials identified mostly did not use standardised, validated assessments — such as the International Prostate Symptom Score or the Boyarsky score — for evaluation of urinary symptom improvement.

Meta-analysis (American Journal of Medicine / PubMed): A systematic review and quantitative meta-analysis was conducted to examine the therapeutic efficacy and tolerability of Pygeum africanum in men with symptomatic BPH. Studies were identified through Medline (1966–2000), Embase, Phytodok, the Cochrane Library, bibliographies, and contact with relevant authors. Randomised trials were included if participants had symptomatic BPH, the intervention was a preparation of P. africanum alone or in combination with other phytotherapeutic agents, a control group received placebo or other pharmacologic therapies, and treatment duration was at least 30 days.

Evidence Strength: The meta-analysis suggests that Pygeum africanum is effective in improving urinary symptoms in men with symptomatic BPH. However, the pooled studies were few in number and placebo-controlled studies did not use standardised instruments. Additional placebo-controlled trials are needed, as well as studies that compare Pygeum africanum to active controls that have been convincingly demonstrated to have beneficial effects on lower urinary tract symptoms related to BPH. Overall, the evidence base for Pygeum in BPH is moderate, supported by a Cochrane-reviewed systematic meta-analysis, though the trials carry methodological limitations (short duration, non-standardised outcome measures, older trial designs).

5.2 Cardiovascular Health and Lipid Profiles — Prunus dulcis (Almond)

Systematic Review and Meta-analysis: Almond intervention in a systematic review and meta-analysis of RCTs significantly decreased total cholesterol (summary net change: −10.69 mg/dL; 95% CI: −16.75 to −4.63 mg/dL), LDL cholesterol (summary net change: −5.83 mg/dL; 95% CI: −9.91 to −1.75 mg/dL), and body weight (summary net change: −1.39 kg).

Evidence suggests that eating nuts may reduce the risk of cardiovascular disease (CVD). A systematic review and meta-analysis of randomised controlled trials (RCTs) evaluating almond consumption and risk factors for CVD searched MEDLINE, Cochrane Central, Commonwealth Agricultural Bureau, and previous systematic reviews from 1990 through June 2017 for RCTs of ≥3 weeks' duration that evaluated almond compared with no almond consumption in adults who were either healthy or at risk for CVD.

Cross-over RCT: Almonds reduce cardiovascular disease risk via cholesterol reduction, anti-inflammation, glucoregulation, and antioxidation. A randomised, controlled, crossover trial was conducted to determine whether addition of 85 g almonds daily to a National Cholesterol Education Program (NCEP) Step 1 diet for 6 weeks would improve vascular function and inflammation in patients with coronary artery disease (CAD). The study duration was 22 weeks, including a 6-week run-in period, two 6-week intervention phases, and a 4-week washout period between phases. A total of 45 CAD patients (27 F / 18 M, 45–77 y) completed the study.

In epidemiological studies, the consumption of almonds has been associated with several therapeutically protective health benefits. Clinical studies have verified the modulatory effects on serum glucose, lipid, and uric acid levels, the regulatory role on body weight, and protective effects against diabetes, obesity, metabolic syndrome, and cardiovascular diseases. Moreover, recent researchers have also confirmed the prebiotic potential of almonds.

The benefit to cardiovascular health of almond consumption has been demonstrated in people living in Canada, China, Taiwan, the United States, and the United Kingdom.

Evidence Strength: The evidence for almonds in lipid reduction and cardiovascular risk factor modification is strong at the level of multiple RCTs and systematic meta-analyses. The most significant results are generally in agreement, providing solid evidence so physicians and nutritionists can feel confident in encouraging the use of almonds in the management of several borderline conditions.

5.3 Gout and Hyperuricaemia — Prunus cerasus (Tart Cherry)

Sour cherries (Prunus cerasus) are rich in vitamins A, C, and E, anthocyanins, and isoflavonoids. Pharmaceutical properties demonstrated include gastroprotective, anti-inflammatory, and antioxidant effects. Their consumption has been found to be beneficial for muscle soreness after exercise, gout, arterial hypertension, and cardiovascular diseases.

In an investigation on gout history, Singh et al. reported a number of outcomes associated with the consumption of cherry-related supplements: a significant reduction in the number of gout flares compared to the previous month, and a trend towards lower urate-lowering therapy medication possession ratio. Further comprehensive trials or long-term follow-up studies will be required to evaluate the efficacy of cherry intake in treating patients with gout or hyperuricaemia.

Evidence Strength: Antioxidant and anti-inflammatory activities have been demonstrated in animal studies. A small number of clinical trials evaluating sour cherry juice have shown limited or equivocal results in arthritis and in alleviating muscle inflammation after strenuous exercise. Limited studies also suggest a possible hypotensive effect and a role in the management of gout and insomnia. Larger, higher-quality clinical trials are needed before sour cherry can be recommended for these uses.

5.4 Sleep Quality — Prunus cerasus (Tart Cherry)

Montmorency tart cherry is the subject of increasing scientific interest due to reported health effects ranging from reducing inflammation and oxidative stress to improving recovery from exercise and boosting sleep quality. Anti-inflammatory and sleep-promoting properties are attributed in part to anthocyanins, which may minimise tryptophan degradation while increasing bioavailability for serotonin synthesis. Additionally, sleep-promoting effects arise from large naturally occurring levels of melatonin.

Clinical trials and studies on these herbs are limited but suggest potential improvements in sleep quality, duration, and nighttime awakening in athletes and adults with insomnia.

Evidence Strength: Preliminary and limited. Evidence consists of a small number of clinical trials, with effects most consistently seen in nocturia and sleep duration. More rigorous RCTs with standardised sleep outcome measures are required.

5.5 Cognitive Function and Mood — Prunus cerasus

RCT: A study aimed to determine the influence of chronic Montmorency cherry (MC) supplementation on cognitive function and mood. In a 3-month double-blinded, placebo-controlled parallel study, middle-aged adults (mean ± SD: 48 ± 6 years) were randomly assigned to either 30 ml twice daily of MC (n = 25) or the same amount of an isoenergetic placebo (n = 25). Cognitive function and mood were assessed before and after supplementation using a computerised cognitive task battery and visual analogue scales, with cerebral blood flow monitored by near-infrared spectroscopy.

Evidence from human trials regarding the influence of cherries on mood and cognition is less consistent. For example, acute cherry intake has not been shown to influence cognitive performance, despite modulating blood flow. Nevertheless, longer-term cherry supplementation has been shown to improve some aspects of cognitive performance.

Evidence Strength: Preliminary. Mechanistic evidence via vasomodulatory and anti-inflammatory pathways is plausible, but human cognitive trials are few and results inconsistent.

5.6 Metabolic Syndrome and Obesity — Prunus cerasus

Overweight and obesity remain major global health challenges and are closely associated with metabolic disturbances, including dyslipidaemia, insulin resistance, hypertension, and chronic low-grade inflammation. Dietary patterns rich in fruits and vegetables contribute to metabolic health, partly due to their complex matrix of bioactive compounds. Tart cherries (Prunus cerasus) are widely consumed in fresh and processed forms and have attracted attention for their potential benefits in obesity-related conditions. A review critically summarised current evidence from in vitro, animal, and human studies investigating the effects of tart cherries and their derived products in overweight and obese individuals (BMI ≥ 25 kg/m²). Animal studies consistently reported anti-inflammatory, antioxidant, and metabolic improvements following tart cherry supplementation.

Evidence Strength: Pre-clinical data are consistent. Human clinical evidence specifically in overweight/obese populations remains limited and is an active area of investigation.

5.7 Anti-inflammatory and Antioxidant Activity — Prunus spinosa

Oxidative post-translational modifications of fibrinogen are associated with the pathogenesis of cardiovascular disorders. Prunus spinosa flower is a herbal medicine used in the adjuvant treatment of CVDs and rich in polyphenolic antioxidants. Extracts demonstrated a reduction in levels of 3-nitrotyrosine of approximately 13.5–33.0% and 58.3–97.1% at 1 µg/mL and 50 µg/mL, respectively. Low molecular weight polyphenols were crucial for the protective activity of the extracts toward fibrinogen and other human plasma components.

Evidence Strength: In vitro and ex vivo only. No human clinical trials have directly tested P. spinosa extracts for cardiovascular endpoints in controlled settings. Evidence is preliminary.

5.8 Prostate Cancer — Prunus africana

The anti-cancer potential of Pygeum africanum has been tested both in vitro (PC-3 and LNCaP cells) and in vivo (TRAMP mouse model). In tissue culture, ethanolic extracts (30%) of Pygeum africanum inhibited the growth of PC-3 and LNCaP cells, induced apoptosis, and altered cell kinetics. Pygeum africanum, which is widely used in Europe and the USA for treatment of BPH, has a significant role in regulation of prostate cancer both in vitro and in vivo, and therefore may be a useful supplement for people at high risk for developing prostate cancer.

Evidence Strength: Pre-clinical only (cell lines and animal models). No human clinical trials have evaluated P. africana specifically for prostate cancer endpoints. This application remains investigational.

6. Body Systems and Health Areas

• Genitourinary system: P. africana for BPH symptom relief (urinary flow, nocturia, residual urine volume) — best-evidenced single indication in this genus for supplement use.
• Cardiovascular system: Almond (P. dulcis) for lipid profile modulation; P. spinosa for potential fibrinogen/oxidative stress protection (in vitro); tart cherry (P. cerasus) for potential blood pressure and endothelial effects.
• Musculoskeletal system: P. cerasus for post-exercise muscle inflammation and recovery; gout/uric acid management.
• Metabolic health: Almonds for glycaemic control, insulin sensitivity, and body weight; tart cherry for metabolic syndrome risk factors.
• Neurological/sleep: Tart cherry melatonin content associated with sleep quality improvement; cognitive function (preliminary).
• Gastrointestinal system: Almonds have confirmed prebiotic potential. Various species used traditionally for gastric complaints.
• Immunological/inflammatory: Multiple Prunus species demonstrate polyphenol-mediated anti-inflammatory effects on immune cells (primarily ex vivo).
• Oncology (investigational): P. africana and P. armeniaca studied in pre-clinical models for antiproliferative effects; not validated in human trials.

7. Dosage Forms and Dosages Reported in Studies

7.1 Prunus africana (Pygeum Bark Extract)

Pygeum has been studied in clinical trials for benign prostatic hypertrophy at daily doses of 25 to 200 mg. It is available as standardised preparations Tadenan and Pigenil. Both are in capsule form and contain 50 mg of Prunus africana extract (pygeum). Recommended dosage is twice daily.

A reported dose of 75–200 mg/day of standardised lipophilic extract (orally, divided once or twice daily) has been used; standardised extracts contain 13% total sterols or 14% triterpenes with 0.5% n-docosanol.

The Cochrane-reviewed trials used treatment periods of 30–120 days, with benefits typically apparent by 6–8 weeks.

7.2 Prunus cerasus (Tart Cherry)

In a 3-month double-blinded, placebo-controlled parallel study, middle-aged adults were randomly assigned to either 30 ml twice daily of Montmorency cherry concentrate or the same amount of an isoenergetic placebo.

7.3 Prunus dulcis (Almond)

A randomised controlled crossover trial investigated whether addition of 85 g almonds daily to a National Cholesterol Education Program diet for 6 weeks would improve vascular function and inflammation in patients with coronary artery disease. A separate non-randomised study used 50 grams of raw almonds consumed daily for 30 days.

8. Safety Considerations and Interactions

8.1 Prunus africana Toxicology

Studies confirmed the safety of the extract at therapeutic dosages, since signs of toxicity were observed only at very high dose levels. Acute and chronic toxicity of the extract was low; signs of toxicity in liver, kidney, and heart were observed only with very high doses.

The lethal dose (LD50) for P. africana was determined to be 2,201.207 mg/kg body weight in an acute murine toxicity study.

Genotoxicity studies gave variable results: the Ames test (strain TA98) gave uniformly negative results, whereas the micronucleus test and the Comet assay gave both positive and negative results. These combined data confirmed the safety of the extract at therapeutic dosages.

The collective evidence underscores the overall non-toxic nature of the P. africana bark extract, providing a foundation for its continued exploration as a therapeutic agent.

Adverse effects of Pygeum africanum in BPH trials were mild and comparable to placebo; the most commonly reported side effect was gastrointestinal discomfort.

8.2 Cyanogenic Glycoside Hazard — Bitter Almond, Apricot Kernels (P. dulcis, P. armeniaca)

Safety evaluations established that sweet almonds are well-tolerated, while bitter almond varieties require strict dosage limitation (≤0.6–1.0 g amygdalin daily) due to cyanogenic glycoside content.

In the field, trees carrying bitter kernels are toxic to humans and consequently need to be removed. The toxicity of bitter almonds is caused by the accumulation of the cyanogenic diglucoside amygdalin, which releases toxic hydrogen cyanide upon hydrolysis.

The acute lethal dose of cyanide for mammals is as low as 0.5 mg CN/kg of body weight; the acute oral lethal dose of HCN for humans is reported to be 0.5–3.5 mg/kg body weight, and the consumption of 50 bitter almonds is deadly for adults. For young children, 5–10 bitter almonds are fatal.

Amygdalin is a medically interesting but controversial compound, as it has anticancer activity on one hand and can be toxic via enzymatic degradation and production of hydrogen cyanide on the other. Despite numerous contributions on cancer cell lines, the clinical evidence for the anticancer activity of amygdalin is not fully confirmed. Moreover, high dose exposures to amygdalin can produce cyanide toxicity.

8.3 Cross-Reactivity and Allergenicity

Several studies have found that P. mume peamaclein (also known as gibberellin-regulated protein or GRP) is a cross-reactive allergen between P. mume and peach (P. persica), and could cause food-dependent exercise-induced anaphylaxis. It may be necessary to remind individuals who are allergic to peaches to avoid eating P. mume.

Almonds may pose a risk for potentially allergic individuals.

8.4 Conservation and Supply Concerns — P. africana

Prunus africana is listed under CITES Appendix II due to overharvesting of wild trees in Cameroon, Madagascar, and other African countries. Worldwide exports of dried bark in 2000 were estimated at 1,350–1,525 metric tons per year, down from a peak of 3,225 tons in 1997.

8.5 General Evidence Gaps and Research Limitations

Additional preclinical and clinical studies are imperative to validate the efficacy and safety of P. africana phytochemicals, whether used individually or in combination, for potential integration into therapeutic practice.

Despite substantial evidence, critical knowledge gaps remain across the genus as a whole. For species such as P. spinosa, evidence remains confined to in vitro and ex vivo models. For P. mume, anticancer and antimicrobial evidence is largely pre-clinical. For P. mira, there are few studies on the pharmacological effects of specific active components and also few clinical studies.

References

• An overview of the health benefits of Prunus species with special reference to metabolic syndrome risk factors — ScienceDirect / Food and Chemical Toxicology (2020)
• A Comprehensive Review of Ethnomedicinal Uses, Phytochemistry, Pharmacology, and Toxicity of Prunus africana (Hook. F.) Kalkman from Africa — Scientifica / PMC (2024)
• Pygeum africanum for the treatment of patients with benign prostatic hyperplasia: a systematic review and quantitative meta-analysis — PubMed / American Journal of Medicine (2000)
• Pygeum africanum for benign prostatic hyperplasia — Cochrane Database / PMC (2002, republished)
• Prostate Enlargement — Cochrane Complementary Medicine Summary
• Chemical comparison of Prunus africana bark and pygeum products marketed for prostate health — PubMed / Journal of Pharmaceutical and Biomedical Analysis (2019)
• Bioactive constituents in Prunus africana: geographical variation throughout Africa — PubMed / Phytochemistry (2012)
• EMA Assessment Report on Prunus africana (Hook f.) Kalkm., cortex
• Almonds (Prunus Dulcis Mill. D. A. Webb): A Source of Nutrients and Health-Promoting Compounds — PMC (2020)
• Almond Consumption and Risk Factors for Cardiovascular Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials — PubMed / Advances in Nutrition (2019)
• Effect of almond consumption on vascular function in patients with coronary artery disease: a randomized, controlled, cross-over trial — PMC
• Prunus amygdalus Batsch (Almond): A comprehensive review — ScienceDirect (2026)
• Polyphenol-rich tart cherries (Prunus cerasus, cv Montmorency) improve sustained attention — PMC (2022)
• Effectiveness of Cherries in Reducing Uric Acid and Gout: A Systematic Review — PMC (2019)
• Is there a role for cherries in the management of gout? — PMC
• Effect of Prunus cerasus (Sour Cherry) on Nephrolithiasis in Children — PMC (2024)
• Tart cherries (Prunus cerasus) and metabolic health in overweight and obesity — Frontiers in Nutrition (2026)
• Polyphenol-Enriched Extracts of Prunus spinosa Fruits: Anti-Inflammatory and Antioxidant Effects — PMC (2022)
• The Effects of Prunus spinosa L. Flower Extracts on Oxidative/Nitrative Modifications of Human Plasma Components — PMC (2021)
• Comprehensive Review of Phytochemical Constituents, Pharmacological Properties, and Clinical Applications of Prunus mume — PMC (2021)
• Anticancer properties of Prunus mume extracts (Chinese plum, Japanese apricot) — ScienceDirect / Journal of Ethnopharmacology (2019)
• Anticancer Potential and Other Pharmacological Properties of Prunus armeniaca L.: An Updated Overview — PMC (2022)
• Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds — PMC (2021)
• Potential Toxic Levels of Cyanide in Almonds (Prunus amygdalus), Apricot Kernels (Prunus armeniaca), and Almond Syrup — PMC (2013)
• Elucidation of the Amygdalin Pathway Reveals the Metabolic Basis of Bitter and Sweet Almonds (Prunus dulcis) — PMC (2018)
• A Review of the Potential of Phytochemicals from Prunus africana Stem Bark for Chemoprevention and Chemotherapy of Prostate Cancer — PubMed (2017)
• The African cherry (Prunus africana): can lessons be learned from an over-exploited medicinal tree? — PubMed (2003)
• Prunus mira Koehne in Sichuan, China: Recorded History as a Medicine and Food — Frontiers in Pharmacology (2022)
• Exploring the phytochemical composition, ethnomedicinal uses, and therapeutic potential of Prunus species — Naunyn-Schmiedeberg's Archives of Pharmacology / Springer (2026)
• Prunus cerasoides D. Don: A Review on Its Ethnomedicinal Uses — Global Research Online